VIPR2 Antibody

Product Specifications

Background

Vasoactive intestinal peptide (VIP; MIM 192320) and pituitary adenylate cyclase activating polypeptide (PACAP; MIM 102980) are homologous peptides that function as neurotransmitters and neuroendocrine hormones. While the receptors for VIP and PACAP share homology, they differ in their substrate specificities and expression patterns. See VIPR1 (MIM 192321) and ADCYAP1R1 (MIM 102981) .

NCBI Gene ID

7434

Swiss Prot

P41587

Accession Number

P41587

Host

Rabbit

Reactivity

Human

Immunogen

This VIPR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 95-123 amino acids from the N-terminal region of human VIPR2.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Cancer, Neuroscience, Signal Transduction, Growth Factors

Purification

This antibody is purified through a protein A column, followed by peptide affinity purification.

Concentration

Batch dependent

Buffer

Supplied in PBS with 0.09% (W/V) sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Calculated Molecular Weight

49 kDa

Fragment

Rabbit Ig

Applications Notes

For WB starting dilution is: 1:1000

Symbol

VIPR2

NCBI Official Name

Vasoactive intestinal polypeptide receptor 2

NCBI Organism

Homo sapiens

Background Reference 01

Kovanen, L., et al. Alcohol Alcohol. 45 (4) :303-311 (2010)

Background Reference 02

Kellogg, D.L. Jr., et al. J. Appl. Physiol. 109 (1) :95-100 (2010)

Background Reference 03

Liu, Y.J., et al. Obesity (Silver Spring) (2010) In press :

Background Reference 04

Yoshida, T., et al. Int. J. Mol. Med. 25 (4) :649-656 (2010)

Other Product Names

Vasoactive intestinal polypeptide receptor 2, VIP-R-2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R-3, PACAP-R3, VPAC2, VIPR2, VIP2R